CytomX Therapeutics Inc.
(CTMX)
undefined
undefined%
At close: undefined
1.12
3.70%
After-hours Dec 13, 2024, 07:57 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -569.00K | -99.32M | -83.61M | -32.88M | -102.24M | -84.60M | -43.10M | -58.90M | -35.37M | -30.31M | -15.14M |
| Depreciation & Amortization | 2.17M | 2.44M | 2.71M | 2.57M | 2.60M | 1.88M | 1.65M | 1.73M | 1.21M | 783.00K | 655.00K |
| Stock-Based Compensation | 8.56M | 13.13M | 13.17M | 14.79M | 19.10M | 16.88M | 11.29M | 10.10M | 3.99M | 553.00K | 343.00K |
| Other Working Capital | -93.64M | 4.47M | -66.21M | 30.89M | -47.74M | -38.20M | 189.91M | 43.32M | -6.13M | 61.46M | 5.50M |
| Other Non-Cash Items | -3.69M | 3.62M | 3.13M | 2.89M | 1.60M | -1.70M | 11.09M | 1.77M | 3.01M | 95.00K | 169.00K |
| Deferred Income Tax | - | - | 272.00K | -236.00K | -2.23M | - | -513.00K | 6.00K | 8.00K | 8.00K | 10.00K |
| Change in Working Capital | -62.51M | -30.65M | -54.70M | 18.13M | -59.32M | -7.98M | 189.97M | 43.26M | -248.00K | 60.67M | 5.96M |
| Operating Cash Flow | -56.03M | -110.79M | -119.03M | 5.26M | -140.48M | -75.52M | 170.37M | -2.03M | -27.41M | 31.80M | -8.01M |
| Capital Expenditures | -840.00K | -1.74M | -1.61M | -2.31M | -3.50M | -3.79M | -1.56M | -2.18M | -1.59M | -1.66M | -732.00K |
| Acquisitions | - | - | -24.10M | 16.41M | -83.20M | -5.93M | 121.27M | 52.00K | - | - | - |
| Purchase of Investments | -424.83M | - | -99.90M | -199.11M | -174.99M | -204.60M | -218.71M | -121.52M | -250.90M | - | - |
| Sales Maturities Of Investments | 275.00M | 100.00M | 124.00M | 182.70M | 258.19M | 214.31M | 99.00M | 169.50M | 122.75M | - | - |
| Other Investing Acitivies | - | 100.00M | 24.10M | -16.41M | 83.20M | 5.93M | -121.27M | 52.00K | -817.00K | - | - |
| Investing Cash Flow | -150.67M | 98.26M | 22.49M | -18.72M | 79.70M | 5.93M | -121.27M | 45.86M | -130.56M | -1.66M | -732.00K |
| Debt Repayment | - | - | - | - | - | - | - | 78.00K | -3.07M | -1.26M | 2.63M |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | -6.71M | - | - |
| Other Financial Acitivies | 30.23M | 648.00K | 2.50M | 5.61M | 1.63M | 5.03M | 3.84M | 918.00K | 81.40M | 26.81M | 62.00K |
| Financial Cash Flow | 30.23M | 648.00K | 110.21M | 16.89M | 1.63M | 139.62M | 23.80M | 996.00K | 153.40M | 25.55M | 2.70M |
| Net Cash Flow | -176.48M | -11.88M | 13.67M | 3.43M | -59.15M | 70.03M | 72.90M | 44.82M | -4.57M | 55.69M | -6.04M |
| Free Cash Flow | -56.88M | -112.53M | -120.64M | 2.95M | -143.98M | -79.31M | 168.81M | -4.21M | -29.01M | 30.14M | -8.74M |